These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 149950)

  • 21. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary 21-deoxycortisol and 17-hydroxyprogesterone in congenital adrenal hyperplasia.
    Milewicz A; Vecsei P; Gruszka S; Bednarek-Tupikowska G; Szymczak J; Grabiński M
    Mater Med Pol; 1984; 16(2-4):91-4. PubMed ID: 6335995
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia.
    Korth-Schutz S; Virdis R; Saenger P; Chow DM; Levine LS; New MI
    J Clin Endocrinol Metab; 1978 Mar; 46(3):452-8. PubMed ID: 156192
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA; Urban MD; Gutai JP; Migeon CJ
    Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma 17-hydroxyprogesterone, 21-deoxycortisol and cortisol in congenital adrenal hyperplasia.
    Franks RC
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1099-102. PubMed ID: 4372245
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood testosterone values in patients with congenital virilizing adrenal hyperplasia.
    Solomon IL; Schoen EJ; Donelan L; Brandt-Erichsen D
    J Clin Endocrinol Metab; 1975 Mar; 40(3):355-62. PubMed ID: 163840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
    Lim YJ; Yong AB; Warne GL; Montalto J
    J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
    McKenna TJ; Jennings AS; Liddle GW; Burr IM
    J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reevaluation of recalled infants by neonatal mass screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Diagnostic value of pregnanetriolone in a single urine specimen using glass capillary gas chromatography].
    Hikita Y
    Nihon Naibunpi Gakkai Zasshi; 1985 Mar; 61(3):197-219. PubMed ID: 3874793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal and clinical responses to prednisone treatment in adolescents with congenital adrenal hyperplasia.
    Zipf WB; Bacon GE; Kelch RP
    Horm Res; 1980; 12(4):206-17. PubMed ID: 6446517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual heterozygotes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Zachmann M; Prader A
    Acta Endocrinol (Copenh); 1978 Mar; 87(3):557-65. PubMed ID: 580145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Einaudi S; Lala R; Corrias A; Matarazzo P; Pagliardini S; de Sanctis C
    J Pediatr Endocrinol; 1993; 6(2):173-8. PubMed ID: 8348221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
    Hughes IA; Winter JS
    J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary and serum steroid concentrations in the management of congenital adrenal hyperplasia. Lack of physiologic correlations.
    Hendricks SA; Lippe BM; Kaplan SA; Lavin N; Mayes DM
    Am J Dis Child; 1982 Mar; 136(3):229-32. PubMed ID: 7064949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary 17 alpha-hydroxyprogesterone in diagnosis and management of congenital adrenal hyperplasia.
    Wong ET; Brown DR; Ulstrom RA; Steffes MW
    J Clin Endocrinol Metab; 1979 Sep; 49(3):377-80. PubMed ID: 468971
    [No Abstract]   [Full Text] [Related]  

  • 38. Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sellers EP; MacGillivray MH
    Endocr Res; 1995 Aug; 21(3):537-44. PubMed ID: 7588424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin output in congenital adrenal hyperplasia before and after adrenal suppression.
    Klingensmith GJ; Wentz AC; Meyer WJ; Migeon CJ
    J Clin Endocrinol Metab; 1976 Oct; 43(4):933-6. PubMed ID: 185235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of congenital adrenal hyperplasia. Urinary steroid estimations--review of their value.
    Bailey CC; Komrower GM; Palmer M
    Arch Dis Child; 1978 Feb; 53(2):132-5. PubMed ID: 646414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.